| Schedule of Condensed Balance Sheets |
Condensed balance sheets
| | | As of | | | | | December 31, 2025 | | | June 30, 2026 | | | | | RMB | | | RMB | | | US$ | | | ASSETS | | | | | | | | | | | Current assets: | | | | | | | | | | | Cash and cash equivalents | | | 7,549 | | | | 6,474 | | | | 954 | | | Amount due from subsidiaries | | | 241,409 | | | | 234,233 | | | | 34,522 | | | Other current assets | | | 800 | | | | — | | | | — | | | Total current assets | | | 249,758 | | | | 240,707 | | | | 35,476 | | | | | | | | | | | | | | | | | Non-current assets | | | | | | | | | | | | | | Intangible assets | | | 10,947 | | | | 10,002 | | | | 1,474 | | | Investment in subsidiaries | | | (167,698 | ) | | | (163,992 | ) | | | (24,169 | ) | | Total non-current assets | | | (156,751 | ) | | | (153,990 | ) | | | (22,695 | ) | | Total assets | | | 93,007 | | | | 86,717 | | | | 12,781 | | | | | As of | | | | | December 31, 2025 | | | June 30, 2026 | | | | | RMB | | | RMB | | | US$ | | | LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | | | | | Accounts payable | | | — | | | | — | | | | — | | | Amount due to subsidiaries | | | 9,142 | | | | 8,801 | | | | 1,297 | | | Total liabilities | | | 9,142 | | | | 8,801 | | | | 1,297 | | | | | | | | | | | | | | | | | Shareholders’ equity: | | | | | | | | | | | | | | Ordinary shares (US$0.00001428571428 par value; 3,500,000,000 and 3,500,000,000 shares authorized; 1,423,285,396 and 1,423,285,396 issued and outstanding as of December 31, 2025 and June 30, 2026, respectively) | | | 126 | | | | 126 | | | | 18 | | | Additional paid-in capital | | | 312,339 | | | | 319,058 | | | | 47,023 | | | Treasury stock | | | — | | | | (50 | ) | | | (6 | ) | | Statutory reserve | | | 7,596 | | | | 7,596 | | | | 1,120 | | | Accumulated deficit | | | (238,117 | ) | | | (247,847 | ) | | | (36,528 | ) | | Accumulated other comprehensive income | | | 1,921 | | | | (967 | ) | | | (143 | ) | | Total shareholders’ equity | | | 83,865 | | | | 77,916 | | | | 11,484 | | | Total liabilities, shareholders’ equity | | | 93,007 | | | | 86,717 | | | | 12,781 | |
|
| Schedule of Condensed Statement of Comprehensive Income |
Condensed statement of comprehensive income | | | For the six months ended June 30, | | | | | 2025 | | | 2026 | | | | | RMB | | | RMB | | | US$ | | | Cost of revenues | | | — | | | | (187 | ) | | | (28 | ) | | Gross loss | | | — | | | | (187 | ) | | | (28 | ) | | Sales and marketing expenses | | | — | | | | — | | | | — | | | General and administrative expenses | | | (25 | ) | | | (8,186 | ) | | | (1,206 | ) | | Research and development expenses | | | (667 | ) | | | (419 | ) | | | (62 | ) | | Total operating expenses | | | (692 | ) | | | (8,605 | ) | | | (1,268 | ) | | Operating loss | | | (692 | ) | | | (8,792 | ) | | | (1,296 | ) | | Exchange gain (loss) | | | (1,606 | ) | | | 1,245 | | | | 183 | | | Share of loss from subsidiaries and Consolidated VIEs | | | (18,996 | ) | | | (2,183 | ) | | | (319 | ) | | Loss before taxes | | | (21,294 | ) | | | (9,730 | ) | | | (1,432 | ) | | Income tax expense | | | — | | | | — | | | | — | | | Net loss | | | (21,294 | ) | | | (9,730 | ) | | | (1,432 | ) | | | | | | | | | | | | | | | | Comprehensive loss | | | | | | | | | | | | | | Net loss | | | (21,294 | ) | | | (9,730 | ) | | | (1,432 | ) | | Other comprehensive loss | | | | | | | | | | | | | | Foreign currency translation adjustment | | | (1,085 | ) | | | (2,888 | ) | | | (426 | ) | | Total comprehensive loss | | | (22,379 | ) | | | (12,618 | ) | | | (1,858 | ) |
|
| Schedule of Condensed Statements of Cash Flows |
Condensed statements of cash flows
| | | For the six months ended June 30, | | | | | 2025 | | | 2026 | | | | RMB | | | RMB | | | US$ | | | Net cash provided by (used in) operating activities | | | (2,784 | ) | | | 7,293 | | | | 1,075 | | | Net cash used in investing activities | | | (917 | ) | | | — | | | | — | | | Net cash provided by financing activities | | | 3,027 | | | | 50 | | | | 7 | | | Effect of exchange rate changes | | | — | | | | (8,418 | ) | | | (1,241 | ) | | Net decrease in cash and cash equivalents | | | (674 | ) | | | (1,075 | ) | | | (159 | ) | | Cash and cash equivalents at beginning of year | | | 10,995 | | | | 7,549 | | | | 1,113 | | | Cash and cash equivalents at end of year | | | 10,321 | | | | 6,474 | | | | 954 | |
|